Collapsing focal segmental glomerulosclerosis: A morphological lesion in search of nosologic identity

Nephro-Urology Monthly

Volumn 3, Issue 4, 2011, Pages 195-201

  Mubarak, Muhammed ^a   Kazi, Javed I ^a  

^a SINDH INSTITUTE OF UROLOGY AND TRANSPLANTATION   (Pakistan)

Author keywords

Focal segmental glomerulosclerosis glomerular visceral epithelial cells end stage kidney disease

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ANTIRETROVIRUS AGENT; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; STEROID;

ARTICLE; CLINICAL FEATURE; COLLAPSING FOCAL SEGMENTAL GLOMERULOSCLEROSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; FOCAL GLOMERULOSCLEROSIS; GEOGRAPHIC DISTRIBUTION; GRAFT FAILURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NEGRO; NEPHROTIC SYNDROME; NONHUMAN; PATHOGENESIS; PREVALENCE; RISK FACTOR; TREATMENT RESPONSE;

EID: 80053035358     PISSN: 22517006     EISSN: 22517014     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Albaqumi M, Barisoni L. Current views on collapsing glomerulopathy. J Am Soc Nephrol. 2008;19(7):1276-81
2. Albaqumi M, Soos TJ, Barisoni L, Nelson PJ. Collapsing glomerulopathy. J Am Soc Nephrol. 2006;17(10):2854-63
3. Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V. Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study. Kidney Int. 1996;50(5):1734-46
4. D'Agati V. Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol. 2003;23(2):117-34
5. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004;43(2):368-82
6. Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol. 2007;2(3):529-42
7. Meyrier AY. Collapsing glomerulopathy: expanding interest in a shrinking tuft. Am J Kidney Dis. 1999;33(4):801-3
8. Haas M, Meehan SM, Karrison TG, Spargo BH. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis. 1997;30(5):621-31
9. Haas M, Spargo BH, Coventry S. Increasing incidence of focalsegmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study. Am J Kidney Dis. 1995;26(5):740-50
10. Laurinavicius A, Hurwitz S, Rennke HG. Collapsing glomerulopathy in HIV and non-HIV patients: a clinicopathological and follow-up study. Kidney Int. 1999;56(6):2203-13
11. Grcevska L, Polenakovik M. Collapsing glomerulopathy: clinical characteristics and follow-up. Am J Kidney Dis. 1999;33(4):652-7
12. Deegens JK, Steenbergen EJ, Borm GF, Wetzels JF. Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population-epidemiology and outcome. Nephrol Dial Transplant. 2008;23(1):186-92
13. Kazi JI, Mubarak M. "Collapsing FSGS, a need of awareness". J Pak Med Assoc. 2009;59(8):583.
14. Mubarak M, Kazi JI. Collapsing FSGS: a clinicopathologic study of 10 cases from Pakistan. Clin Exp Nephrol. 2010;14(3):222-7
15. Agrawal V, Vinod PB, Krishnani N, Sharma RK. A case of collapsing glomerulopathy associated with febrile illness. Indian J Pathol Microbiol. 2008;51(4):509-11
16. Nada R, Kharbanda JK, Bhatti A, Minz RW, Sakhuja V, Joshi K. Primary focal segmental glomerulosclerosis in adults: is the Indian cohort different? Nephrol Dial Transplant. 2009;24(12):3701-7
17. Weiss MA, Daquioag E, Margolin EG, Pollak VE. Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": a new clinicopathologic entity? Am J Kidney Dis. 1986;7(1):20-8
18. Detwiler RK, Falk RJ, Hogan SL, Jennette JC. Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int. 1994;45(5):1416-24
19. D'Agati V, Suh JI, Carbone L, Cheng JT, Appel G. Pathology of HIVassociated nephropathy: a detailed morphologic and comparative study. Kidney Int. 1989;35(6):1358-70
20. D'Agati V, Appel GB. Renal pathology of human immunodeficiency virus infection. Semin Nephrol. 1998;18(4):406-21
21. Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH, et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int. 2001;59(6):2126-33
22. Moudgil A, Shidban H, Nast CC, Bagga A, Aswad S, Graham SL, et al. Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin. Transplantation. 1997;64(12):1847-50
23. Tanawattanacharoen S, Falk RJ, Jennette JC, Kopp JB. Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis. Am J Kidney Dis. 2000;35(6):1166-74
24. Bennett AN, Peterson P, Sangle S, Hangartner R, Abbs IC, Hughes GR, et al. Adult onset Still's disease and collapsing glomerulopathy: successful treatment with intravenous immunoglobulins and mycophenolate mofetil. Rheumatology (Oxford). 2004;43(6):795-9
25. Amoura Z, Georgin-Lavialle S, Haroche J, Merrien D, Brocheriou I, Beaufils H, et al. Collapsing glomerulopathy in systemic autoimmune disorders: a case occurring in the course of full blown systemic lupus erythematosus. Ann Rheum Dis. 2006;65(2):277-8
26. Kunin M, Kopolovic J, Avigdor A, Holtzman EJ. Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient. Nephrol Dial Transplant. 2004;19(3):723-6
27. Markowitz GS, Appel GB, Fine PL, Fenves AZ, Loon NR, Jagannath S, et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol. 2001;12(6):1164-72
28. Stokes MB, Davis CL, Alpers CE. Collapsing glomerulopathy in renal allografts: a morphological pattern with diverse clinicopathologic associations. Am J Kidney Dis. 1999;33(4):658-66
29. Meehan SM, Pascual M, Williams WW, Tolkoff-Rubin N, Delmonico FL, Cosimi AB, et al. De novo collapsing glomerulopathy in renal allografts. Transplantation. 1998;65(9):1192-7
30. Gupta R, Sharma A, Agarwal SK, Dinda AK. Collapsing glomerulopathy in renal allograft biopsies: A study of nine cases. Indian J Nephrol. 2011;21(1):10-3
31. Nadasdy T, Allen C, Zand MS. Zonal distribution of glomerular collapse in renal allografts: possible role of vascular changes. Hum Pathol. 2002;33(4):437-41
32. Thadhani R, Pascual M, Nickeleit V, Tolkoff-Rubin N, Colvin R. Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease. Lancet. 1996;347(8996):231-3
33. Canaud G, Bruneval P, Noel LH, Correas JM, Audard V, Zafrani L, et al. Glomerular collapse associated with subtotal renal infarction in kidney transplant recipients with multiple renal arteries. Am J Kidney Dis. 2010;55(3):558-65
34. Barisoni L, Kriz W, Mundel P, D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 1999;10(1):51-61
35. Bariety J, Nochy D, Mandet C, Jacquot C, Glotz D, Meyrier A. Podocytes undergo phenotypic changes and express macrophagicassociated markers in idiopathic collapsing glomerulopathy. Kidney Int. 1998;53(4):918-25
36. Barisoni L, Mokrzycki M, Sablay L, Nagata M, Yamase H, Mundel P. Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int. 2000;58(1):137-43
37. Shankland SJ, Eitner F, Hudkins KL, Goodpaster T, D'Agati V, Alpers CE. Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation. Kidney Int. 2000;58(2):674-83
38. Gulati A, Sharma A, Hari P, Dinda AK, Bagga A. Idiopathic collapsing glomerulopathy in children. Clin Exp Nephrol. 2008;12(5):348-53
39. Korbet SM. Treatment of primary focal segmental glomerulosclerosis. Kidney Int. 2002;62(6):2301-10
40. Ponticelli C, Villa M, Banfi G, Cesana B, Pozzi C, Pani A, et al. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis. 1999;34(4):618-25
41. Burgess E. Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int Suppl. 1999;70:S26-32.